Literature DB >> 17626290

Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.

Peter J Dyck1, P James B Dyck, Christopher J Klein, Stephen D Weigand.   

Abstract

In spite of extensive studies it is unclear whether impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), i.e., impaired glucose metabolism (IGM), causes diabetic sensorimotor polyneuropathy (DSPN) or chronic idiopathic axonal polyneuropathy (CIAP); the results and conclusions vary considerably in different studies. Some studies suggest that IGM is a common and important cause of CIAP, whereas others do not. On reviewing these data, we judge that a considerable degree of this disparity may relate to differences in selection of patients, choice of controls, assessment of chronic glycemic exposure and of diabetic complications, and statistical power. Here we review previous studies, list the reasons that the issue needs further study, and outline a study now in progress to address the question more definitively.

Entities:  

Mesh:

Year:  2007        PMID: 17626290     DOI: 10.1002/mus.20846

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  24 in total

1.  Tests and expenditures in the initial evaluation of peripheral neuropathy.

Authors:  Brian Callaghan; Ryan McCammon; Kevin Kerber; Xiao Xu; Kenneth M Langa; Eva Feldman
Journal:  Arch Intern Med       Date:  2012-01-23

Review 2.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

3.  Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Authors:  Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengul; Onder Us; Kubilay Karsidag
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

4.  Does prediabetes cause small fiber sensory polyneuropathy? Does it matter?

Authors:  C D Kassardjian; P J B Dyck; J L Davies; Rickey E Carter; P J Dyck
Journal:  J Neurol Sci       Date:  2015-05-27       Impact factor: 3.181

5.  Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set.

Authors:  Mitra Tavakoli; Maryam Ferdousi; Ioannis N Petropoulos; Julie Morris; Nicola Pritchard; Andrey Zhivov; Dan Ziegler; Danièle Pacaud; Kenneth Romanchuk; Bruce A Perkins; Leif E Lovblom; Vera Bril; J Robinson Singleton; Gordon Smith; Andrew J M Boulton; Nathan Efron; Rayaz A Malik
Journal:  Diabetes Care       Date:  2015-01-29       Impact factor: 19.112

6.  Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.

Authors:  Sergey Lupachyk; Pierre Watcho; Nailia Hasanova; Ulrich Julius; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 7.  Therapeutic strategies for diabetic neuropathy.

Authors:  Ali A Habib; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

8.  Performance-based physical functioning and peripheral neuropathy in a population-based cohort of women at midlife.

Authors:  Kelly R Ylitalo; William H Herman; Siobán D Harlow
Journal:  Am J Epidemiol       Date:  2013-03-22       Impact factor: 4.897

Review 9.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

10.  Neuropathy of impaired glucose tolerance and its measurement.

Authors:  Andrew J M Boulton; Rayaz A Malik
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.